Analysis of microorganisms causing acute upper respiratory tract infection using a multiplex polymerase chain reaction during COVID-19 epidemic - Analysis of microorganisms causing acute upper respiratory tract infection using a multiplex polymerase chain reaction during COVID-19 epidemic

Department of Infection Control and Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital0 sites411 target enrollmentJanuary 11, 2022

Conditionsupper respiratory tract inflammation

Overview

Phase: 未知
Intervention: Not specified
Conditions: upper respiratory tract inflammation
Sponsor: Department of Infection Control and Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital
Enrollment: 411
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The most common diagnosis was acute upper respiratory tract infection (344/411), followed by acute bronchitis or pneumonia and pharyngitis. The most common causative microorganism of upper respiratory tract infection was Coronavirus NL63 (46/344: 13.4%), followed by Rhinovirus / Enterovirus (12.2%) and SARS-CoV-2 (1.7%). On the other hand, SARS-CoV-2 (11/43: 25.6%) was the most common virus causing acute bronchitis or pneumonia.

Registry

who.int

Start Date

January 11, 2022

End Date

May 31, 2021

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Department of Infection Control and Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Cases judged to require hospitalization, urinary tract infections and gastroenteritis that are not similarly diagnosed as upper respiratory tract infections